Australia's Cambium Bio gains after premium share placement
22/07/2026 05:36
BUZZ-Australia's Cambium Bio gains after premium share placement ** Shares of Australia's Cambium Bio CMB.AX rise as much as 5% to A$0.43, highest since July 3
** Biotechnology compnay receives firm commitments to raise A$1 million($700,100.00) via share placements
** Issue price of A$0.48 per share represents 17.1% premium to stock's last close
** Funds raised to form part of co's broader ongoing capital raising strategy to support Phase 3 trial of Elate Ocular for treatment for dry eye disease
** Including session's move, stock down 8.5% YTD
($1 = 1.4284 Australian dollars)
(Reporting by Shravya Marakini)
Recent news on Cambium Bio
See all newsAustralia's Cambium Bio hits near three-month high on share placement at premium
Brief: Cambium Bio Appoints Olga Smejkalova As Company Secretary
Australia's Cambium Bio gains after premium share placement
Brief: Cambium Bio Raises A$1 MLN At A$0.48 Per Share
Brief: Cambium Bio Receives A$2.4 Million Investment From Zheng Yang Biomedical Technology